Irinotecan Hydrochloride
- Molecular Formula: C33H38N4O6·HCl·3H2O
- Cas No.: 100286-90-6; 136572-09-3 (API)
- EINECS No.: 1308068-62; 603-967-2
- Execution standard: USP, EP
Application:
Irinotecan has different effects on lung cancer (small cell lung cancer, non small cell lung cancer), colon cancer, rectal cancer, ovarian cancer, cervical cancer, gastric cancer, lymphatic cancer, breast cancer, leukemia, etc., especially for small cell lung cancer and colon cancer, which exceeds the current anticancer drug activity.